Literature DB >> 8992019

Fluoroquinolones in animal health.

S A Brown1.   

Abstract

The fluoroquinolones are a series of synthetic antibacterial agents that are undergoing extensive investigation for both human and veterinary use in the treatment of a variety of bacterial infections. These agents work through the inhibition of DNA gyrase, interfering with the supercoiling of bacterial chromosomal material. As a result, these agents are rapidly bactericidal primarily against gram-negative bacteria, mycoplasma, and some gram-positive bacteria, with most having little to no activity against group D streptococci and obligate anaerobic bacteria. Resistance develops slowly and is almost always chromosomal and not plasmid-mediated. However, development of resistance to the fluoroquinolones and transfer of that resistance among animal and human pathogens have become a hotly debated issue among microbiologists. The fluoroquinolones are a current antimicrobial class whose use in veterinary medicine is being scrutinized. From a pharmacokinetic perspective, these agents are variably but well absorbed from the gastrointestinal tract and almost completely absorbed from parenteral injection sites, and they are well distributed to various tissues in the body. The fluoroquinolones are metabolized and renally excreted, with many of them having approximately equal excretion by the hepatic and the renal excretory systems. The primary toxicity observed at therapeutic doses involves the gastrointestinal system and phototoxicity, although at higher doses central nervous system toxicity and ocular cataracts are observed. Administration to immature animals may result in erosive arthropathies at weight-bearing joints, and administration of high doses to pregnant animals results in maternotoxicity and occasionally embryonic death. The fluoroquinolones are approved for indications such as urinary tract infections and soft tissue infections in dogs and cats and colibacillosis in poultry. Approval for bovine respiratory disease in the United States is being sought. Other indications for which the fluoroquinolones have been used in animal health include deep-seated infections, prostatitis, and other bacterial infections resistant to standard antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8992019     DOI: 10.1111/j.1365-2885.1996.tb00001.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  43 in total

1.  Some pharmacokinetic data for danofloxacin in healthy goats.

Authors:  M Atef; A Y El-Gendi; M M Amer; A M Abd El-Aty
Journal:  Vet Res Commun       Date:  2001-07       Impact factor: 2.459

2.  Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus.

Authors:  I A Parshikov; J P Freeman; J O Lay; R D Beger; A J Williams; J B Sutherland
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

3.  Cytotoxic and genotoxic effects induced by enrofloxacin-based antibiotic formulation Floxagen® in two experimental models of bovine cells in vitro: peripheral lymphocytes and cumulus cells.

Authors:  Juan Patricio Anchordoquy; Juan Mateo Anchordoquy; Noelia Nikoloff; Rocío Gambaro; Gisel Padula; Cecilia Furnus; Analía Seoane
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-30       Impact factor: 4.223

4.  Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis).

Authors:  Ravinder Sappal; Rakesh Kumar Chaudhary; Harpal Singh Sandhu; Pritam Kaur Sidhu
Journal:  Vet Res Commun       Date:  2009-03-19       Impact factor: 2.459

Review 5.  Use of antimicrobial drugs in veterinary practice.

Authors:  A M Johnston
Journal:  BMJ       Date:  1998-09-05

6.  Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China.

Authors:  Xiuting He; Zhaohui Wang; Xiangping Nie; Yufen Yang; Debo Pan; Anna O W Leung; Zhang Cheng; Yongtao Yang; Kaibin Li; Kunci Chen
Journal:  Environ Geochem Health       Date:  2011-09-01       Impact factor: 4.609

7.  The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck.

Authors:  L Intorre; G Mengozzi; S Bertini; M Bagliacca; E Luchetti; G Soldani
Journal:  Vet Res Commun       Date:  1997-02       Impact factor: 2.459

8.  Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of Dicural.

Authors:  A M Abd El-Aty; A Goudah; M Ismail; M Shimoda
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

9.  Long depletion time of enrofloxacin in rainbow trout (Oncorhynchus mykiss).

Authors:  Dario Lucchetti; Laura Fabrizi; Emilio Guandalini; Elisabetta Podestà; Luigi Marvasi; Anna Zaghini; Ettore Coni
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration.

Authors:  Ayman Goudah; Sherifa Hasabelnaby
Journal:  Vet Med Int       Date:  2010-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.